Once weekly insulin: Reinventing the insulin experience

Novo Nordisk A/S |
Thursday

Chair: Tina Vilsbøll (DNK)

First phase 3 evidence for a once-weekly insulinStephen Bain (UK)
Athena Philis-Tsimikas (USA)
Advancing diabetes management with once-weekly insulin
Panel discussion and Q&A
All faculty